Get started
Author

Rebecca W. Powell

Observed names: R W Powell, R. Powell, Rebecca Powell, Rebecca W Powell
OpenAlex ID: A5049902478
Gene Array and Fluorescence In situ Hybridization Biomarkers of Activity of Saracatinib (AZD0530), a Src Inhibitor, in a Preclinical Model of Colorectal Cancer
2010 · John J. Arcaroli, Basel M. Touban, et al. · Clinical Cancer Research · 64
Common PIK3CA Mutants and a Novel 3′ UTR Mutation Are Associated with Increased Sensitivity to Saracatinib
2012 · John J. Arcaroli, Kevin S. Quackenbush, et al. · Clinical Cancer Research · 42
Tumours with elevated levels of the Notch and Wnt pathways exhibit efficacy to PF-03084014, a γ-secretase inhibitor, in a preclinical colorectal explant model
2013 · J J Arcaroli, K S Quackenbush, et al. · British Journal of Cancer · 41
PDF
ALDH+ tumor‐initiating cells exhibiting gain in NOTCH1 gene copy number have enhanced regrowth sensitivity to a γ‐secretase inhibitor and irinotecan in colorectal cancer
2012 · John J. Arcaroli, Rebecca W. Powell, et al. · Molecular Oncology · 33
Biomarker‐driven trial in metastatic pancreas cancer: feasibility in a multicenter study of saracatinib, an oral S rc inhibitor, in previously treated pancreatic cancer
2012 · John Arcaroli, Kevin Quackenbush, et al. · Cancer Medicine · 23
PDF
Supplementary Figure 1, Tables 1-3 from Common PIK3CA Mutants and a Novel 3′ UTR Mutation Are Associated with Increased Sensitivity to Saracatinib
2023 · John J. Arcaroli, Kevin S. Quackenbush, et al.
Data from Common PIK3CA Mutants and a Novel 3′ UTR Mutation Are Associated with Increased Sensitivity to Saracatinib
2023 · John J. Arcaroli, Kevin S. Quackenbush, et al.
Data from Common PIK3CA Mutants and a Novel 3′ UTR Mutation Are Associated with Increased Sensitivity to Saracatinib
2023 · John J. Arcaroli, Kevin S. Quackenbush, et al.
Supplementary Figure 1, Tables 1-3 from Common PIK3CA Mutants and a Novel 3′ UTR Mutation Are Associated with Increased Sensitivity to Saracatinib
2023 · John J. Arcaroli, Kevin S. Quackenbush, et al.
PDF
Predicting outcomes in patients with advanced malignancies treated on Phase 1 clinical trials.
2015 · Kit Man Wong, Dexiang Gao, et al. · Journal of Clinical Oncology
Abstract 5050: Biomarkers for sensitivity to gamma secretase inhibitors in mouse models of pancreatic adenocarcinoma
2011 · Arvind Dasari, Rebecca W. Powell, et al. · Cancer Research
Abstract 5190: Biomarkers of sensitivity to PF-03084014, a γ-secretase Inhibitor, in a preclinical model of colorectal cancer
2011 · Rebecca W. Powell, Aik Choon Tan, et al. · Cancer Research
Management of esophageal cancer in an elderly UK population
2008 · N. Dorey, R. Powell, et al. · Journal of Clinical Oncology
Works count: 14
Citation count: 203
H-index: 5
I10-index: 5
Year
Topic
Type